Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 2 | 100,0 % | 7 | 100,0 % | +192.02% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 7 | 100,0 % | +192.02% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 01.01.83 |
Anthony Marucci
FOU | Founder | 62 | 01.01.83 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 01.04.09 |
Diane Young
CTO | Chief Tech/Sci/R&D Officer | 68 | 08.07.19 |
Sarah Cavanaugh
ADM | Chief Administrative Officer | 49 | 01.08.12 |
Freddy Jimenez
LAW | General Counsel | 55 | 01.02.16 |
General Counsel | 67 | 03.10.17 | |
Richard Wright
PRN | Corporate Officer/Principal | 60 | 01.01.12 |
Corporate Officer/Principal | 52 | 01.01.09 | |
Ronald Pepin
PRN | Corporate Officer/Principal | 68 | 07.07.11 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 01.03.08 |
Cheryl Cohen
BRD | Director/Board Member | 58 | 16.06.22 |
Harry Penner
BRD | Director/Board Member | 78 | 01.01.97 |
James Marino
BRD | Director/Board Member | 74 | 08.03.17 |
Karen Shoos
CHM | Chairman | 70 | 01.05.01 |
Anthony Marucci
FOU | Founder | 62 | 01.01.83 |
Garry Neil
BRD | Director/Board Member | 70 | 16.06.22 |
Keith Brownlie
BRD | Director/Board Member | 71 | 15.06.17 |
Rita Jain
BRD | Director/Board Member | 62 | 16.02.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 65 910 548 | 65 721 561 ( 99,71 %) | 0 | 99,71 % |
Unternehmenskontakt
Celldex Therapeutics, Inc.
Perryville III Building 53 Frontage Road
08827, Hampton
+908 200 7500
http://www.celldex.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25.83% | 46.56 Mrd. | |
+45.38% | 41.67 Mrd. | |
+0.69% | 41.16 Mrd. | |
+30.52% | 32.4 Mrd. | |
+22.30% | 28.18 Mrd. | |
-6.35% | 28.1 Mrd. | |
+49.25% | 14.52 Mrd. | |
+49.18% | 13.74 Mrd. | |
+3.45% | 12.17 Mrd. |